Our Practice supports ethically approved clinical research.

Woodseats Medical Centre is part of the Yorkshire & Humber Clinical Research Network and works collaboratively with other local practices to assist with research studies.

Only ethically approved research studies that our GPs think may be of benefit to our patients and the wider population are selected. In order to identify patients that are eligible to take part in the study our doctors or nurses perform a search of our patient records. We then write to our selected patients with information provided by the research body (usually a university), for patients to consider if they would like to take part.

Patients can then choose to contact the researchers directly and elect to take part. The surgery does not pass any patient details to 3rd parties and we identify patients ourselves.

There is no obligation to take part and patients can expect a detailed explanation from the researchers before committing.

All research bodies that the Research Network engages with are fully accredited and held to strict governance standards. Most are not for profit, however some pharmaceutical companies sponsor projects that will improve patient care in the NHS.

If you receive a letter inviting you to take part this is because you fit the criteria to be included in the research study. The list of eligible patients is reviewed by a GP prior to letters being sent to prevent inappropriate invitations. However, if you do receive an invitation and feel it is not appropriate, please contact the surgery.

Examples of the current studies we are involved with:


The FAST study is designed to find out whether febuxostat is safer, less safe or just as safe as allopurinol for long term use in practice. This information will be of great value to everyone who needs to take these drugs on a regular basis. It will allow doctors to make the best choice for people with gout, not just for their joint pain and arthritis but also for any associated medical disorders they may have and for their general health. 


Allopurinol is a medication usually used to prevent gout. Allopurinol has several positive effects on the heart and blood vessels, is inexpensive and is already widely used in patients. Ischaemic heart disease is common in people in the UK. In this study, we want to improve the treatment of patients with ischaemic heart disease. We want to investigate whether adding allopurinol to these patients’ usual medications will reduce their risk of having a stroke, heart attack or of dying due to cardiovascular disease.


Aspirin is a valuable drug, often prescribed at low doses to reduce the chance of heart attacks and strokes. However, aspirin can sometimes cause internal bleeding from ulcers. We are trying to find out whether this occurs more in patients who carry the bacteria Helicobacter (H.) pylori. This bacteria is present in the stomach of more than half the world’s population who usually do not know they have it because it seldom causes symptoms. We are conducting a study to find out whether getting rid of the bacteria with antibiotics reduces the chance of ulcer bleeding.


REACT (Relatives Education And Coping Toolkit) is online peer-supported toolkit for relatives of people with psychosis or bipolar disorder.
The aim of this study is to test the effectiveness of REACT for reducing relatives’ distress and explore the costs involved in delivering this intervention.

Call 111 when you need medical help fast but it’s not a 999 emergencyNHS ChoicesThis site is brought to you by My Surgery Website